Evidence map›Paper›PMID 36678578›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Numerical and Machine Learning Analysis of the Parameters Affecting the Regionally Delivered Nasal Dose of Nano- and Micro-Sized Aerosolized Drugs.

Ali Farnoud, Hesam Tofighian, Ingo Baumann, Kaveh Ahookhosh, Oveis Pourmehran, Xinguang Cui, Vincent Heuveline, Chen Song, Sarah Vreugde, Peter-John Wormald and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Influencing factors of particle deposition in the human nasal cavity.Laryngoscope investigative otolaryngology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ali FarnoudComputational Health Center, Helmholtz Munich, 85764 Neuherberg, Germany.ORCID 0000-0002-9298-5497
Hesam TofighianDepartment of Mechanical Engineering, Amirkabir University of Technology, Tehran 1591634311, Iran.ORCID 0000-0001-9903-3985
Ingo BaumannDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical Center of Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0001-6945-2601
Kaveh AhookhoshBiomedical MRI and MoSAIC, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1789-2303
Oveis PourmehranDepartment of Otolaryngology, Head and Neck Surgery, Adelaide Medical School, The University of Adelaide, Adelaide 5011, Australia.
Xinguang CuiSchool of Aerospace Engineering, Huazhong University of Science and Technology, Wuhan 430074, China.
Vincent HeuvelineEngineering Mathematics and Computing Lab (EMCL), Heidelberg University, 69120 Heidelberg, Germany.
Chen SongEngineering Mathematics and Computing Lab (EMCL), Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0003-3775-8184
Sarah VreugdeDepartment of Otolaryngology, Head and Neck Surgery, Adelaide Medical School, The University of Adelaide, Adelaide 5011, Australia.
Peter-John WormaldDepartment of Otolaryngology, Head and Neck Surgery, Adelaide Medical School, The University of Adelaide, Adelaide 5011, Australia.
Michael P MendenComputational Health Center, Helmholtz Munich, 85764 Neuherberg, Germany.ORCID 0000-0003-0267-5792
Otmar SchmidComprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), 81377 Munich, Germany.ORCID 0000-0002-8012-7786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nasal epithelium is an important target for drug delivery to the nose and secondary organs such as the brain via the olfactory bulb. For both topical and brain delivery, the targeting of specific nasal regions such as the olfactory epithelium (brain) is essential, yet challenging. In this study, a numerical model was developed to predict the regional dose as mass per surface area (for an inhaled mass of 2.5 mg), which is the biologically most relevant dose metric for drug delivery in the respiratory system. The role of aerosol diameter (particle diameter: 1 nm to 30 µm) and inhalation flow rate (4, 15 and 30 L/min) in optimal drug delivery to the vestibule, nasal valve, olfactory and nasopharynx is assessed. To obtain the highest doses in the olfactory region, we suggest aerosols with a diameter of 20 µm and a medium inlet air flow rate of 15 L/min. High deposition on the olfactory epithelium was also observed for nanoparticles below 1 nm, as was high residence time (slow flow rate of 4 L/min), but the very low mass of 1 nm nanoparticles is prohibitive for most therapeutic applications. Moreover, high flow rates (30 L/min) and larger micro-aerosols lead to highest doses in the vestibule and nasal valve regions. On the other hand, the highest drug doses in the nasopharynx are observed for nano-aerosol (1 nm) and fine microparticles (1-20 µm) with a relatively weak dependence on flow rate. Furthermore, using the 45 different inhalation scenarios generated by numerical models, different machine learning models with five-fold cross-validation are trained to predict the delivered dose and avoid partial differential equation solvers for future predictions. Random forest and gradient boosting models resulted in R

Indexed as

machine learningnanodrug deliverynasal drug deliverynumerical modellingtargeted drug delivery

Identifiers

PMID36678578
PMCPMC9863249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.